Aspects of digestive tract tumors in Down syndrome: A literature review

Digestive Diseases and Sciences

Volumn 51, Issue 11, 2006, Pages 2053-2061

  Satgé, Daniel ^a   Sasco, Annie J ^b   Vekemans, Michel J J ^c   Portal, Marie Laure ^a   Fléjou, Jean François ^d  

^a CENTRE HOSPITALIER   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Digestive tract neoplasms; Down syndrome; Gallbladder cancer; Trisomy 21; Tumor suppressor genes

Indexed keywords

BENIGN TUMOR; BILE DUCT TUMOR; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHILDHOOD CANCER; DELAYED DIAGNOSIS; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM TUMOR; DISEASE COURSE; DOWN SYNDROME; EPIDEMIOLOGICAL DATA; ESOPHAGUS TUMOR; FETAL TUMOR; FOLLOW UP; GALLBLADDER TUMOR; HUMAN; INTELLECTUAL IMPAIRMENT; LIVER TUMOR; MENTAL DEFICIENCY; PAIN; PANCREAS TUMOR; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOTUMOR; REVIEW; RISK FACTOR; SMALL INTESTINE TUMOR; STOMACH TUMOR; SYMPTOM;

COLORECTAL NEOPLASMS; COMORBIDITY; DIGESTIVE SYSTEM NEOPLASMS; DOWN SYNDROME; ESOPHAGEAL NEOPLASMS; INCIDENCE; LIVER NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 33751532420     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9131-3     Document Type: Review

References (103)

1. Buchin PJ, Levy JS, Schullinger JN (1986) Down's syndrome and the gastrointestinal tract. J Clin Gastroenterol 8:111-114
2. Rogers PT, Coleman M (1992) The gastrointestinal system. In Medical care in Down syndrome. A preventive medicine approach. Marcel Dekker, New York, pp 169-178
3. Baird PA, Sadovnick AD (1989) Life tables for Down syndrome. Hum Genet 82:291-292
4. Olson LE, Richtsmeier JT, Leszl J, Reeves RH (2004) A chromosome 21 critical region does not cause specific down syndrome phenotypes. Science 306:687-690
5. Satgé D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M (1998) A tumor profile in Down syndrome. Am J Med Genet 78:207-216
6. Hasle H, Clemmensen IH, Mikkelsen M (2000) Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355:165-169
7. Hennequin M, Morin C, Feine JS (2000) Pain expression and stimulus localisation in individuals with Down's syndrome. Lancet 356:1882-1887
8. Hennequin M, Allison PJ, Veyrune JL (2000) Prevalence of oral health problems in a group of individuals with Down syndrome in France. Dev Med Child Neurol 42:691-698
9. Eversole LR, Sorenson HW (1974) Oral florid papillomatosis in Down's syndrome. Oral Surg 37:202-207
10. De la Torre C, Cruces MJ (1991) Cowden's disease and Down syndrome. J Am Acad Dermatol 25:909-911
11. Petri WH, Mack R, Hsu M, Yamashita DD (1992) A submucosal mass in the floor of the mouth. J Oral Maxillofac Surg 50:1087-1090
12. Scholl T, Stein Z, Hansen H (1982) Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev Med Child Neurol 24:817-829
13. Boker LK, Blumstein T, Sadetzki S, Luxenburg O, Litvak I, Akstein E, Modan B (2001) Incidence of leukemia and other cancers in Down syndrome subjects in Israel. Int J Cancer 93:741-744
14. Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami HO, Olsen JH, Nyren O, Fraumeni JFJr (2003) Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163:705-711
15. Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down's syndrome in the United States from 1983 to 1997: A population-based study. Lancet 359:1019-1025
16. van Schrojenstein Lantman-de Valt HMJ, Schupf N, Patja K (2002) Reproductive and physical health. In Walsh PN, Heller T (eds) Health in women with intellectual disabilities. Blackwell Science, London, 2002, pp 22-40
17. Srinivasan K, Kameswaram M (2002) Screening for oropharyngeal cancer. In Aziz K, Wu GY (eds) Cancer screening. Humana Press, Totowa, NJ, pp 129-138
18. Yamamoto N, Uzawa K, Miya T, Watanabe T, Yokoe H, Shibahara T, Noma H, Tanzawa H (1999) Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: Evidence for three discrete tumor suppressor gene loci. Oncol Rep 6:1223-1227
19. Chen L, Wong MP, Cheung LK, Samaranayake LP, Baum L, Samman N (2005) Frequent allelic loss of 21q11.1 approximately q21.1 region in advanced stage oral squamous cell carcinoma. Cancer Genet Cytogenet 159:37-43
20. Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H, Yamamoto T (1998) ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16:2687-2693
21. Hordijk PL, Ten Klooster JP, Van Der Kammen RA, Michiels F, Oomen LC, Collard JG (1997) Inhibition of invasion of epithelial cells by Tiam 1-Rac signaling. Science 278:1464-1466
22. Lutfalla G, Roeckel N, Mogensen KE, Mattei MG, Uze G (1990) Assignment of the human interferon-( receptor gene to chromosome 21q22.1 by in situ hybridization. J Interferon Res 10:515-517
23. Gutterman JU (1994) Cytokine therapeutics: Lessons from interferon α. Proc Natl Acad Sci USA 91:1198-1205
24. Rose JS, Kassner EG, Jurgens KH, Farman J (1975) Congenital oesophageal strictures due to cartilaginous rings. Br J Radiol 48:16-18
25. Smith CW, Murray GF, Wilcox BR (1976) Intramural esophageal hamartoma. J Thor Cardiovasc Surg 72:315-318
26. Halfhide BC, Ginai AZ, Spoelstra HA, Dees J, Vuzevski VD (1995) Case report: A hamartoma presenting as a giant oesophageal polyp. Br J Radiol 68:85-88
27. Boker LK, Merrick J (2002) Cancer incidence in persons with Down syndrome in Israel. Down Syndrome Res Pract 8:31-36
28. Hermon C, Alberman E, Beral V, Swerdlow AJ (2001) Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings. Ann Hum Genet 65:167-176
29. Böhmer CJM, Klinkenberg-Knol EC, Niezen-de Boer RC, Meuwissen SG (1997) The age-related incidences of oesophageal carcinoma in intellectually disabled individuals in institutes in the Netherlands. Eur J Gastroenterol Hepatol 9:589-592
30. Ammann J, Schärli A (1977) Congenital duodenal membrane as cause for hiatus hernia, stricture of the oesophagus, and stricture carcinoma in an adult with Down's syndrome. Prog Pediatr Surg 10:33-34
31. Jancar J (1990) Cancer and mental handicap, a further study (1976-85). Br J Psychiatry 156:531-533
32. Gabbert HE, Shimoda T, Hainaut P, Nakamura Y, Field JK, Inoue H (2000) Squamous cell carcinoma of the oesophagus. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 11-19
33. Li X, Lu J-Y, Zhao L-Q, Wang XQ, Liu GL, Liu Z, Zhou CN, Wu M, Liu ZH (2003) Overexpression of ETS2 in human esophageal squamous cell carcinoma. World J Gastroenterol 15:205-208
34. Aoki T, Mori T, Du X, Nisihira T, Matsubara T, Nakamura Y (1994) Allelotype study of esophageal carcinoma. Genes Chromos Cancer 10:177-182
35. Mayama T, Fukushige S, Shineha R, Nishihira T, Satomi S, Horii A (2000) Frequent loss of copy number on the long arm of chromosome 21 in human esophageal squamous cell carcinoma. Int J Oncol 17:245-252
36. Zarate N, Mearin F, Hidalgo A, Malagelada JR (2001) Prospective evaluation of esophageal motor dysfunction in Down's syndrome. Am J Gastroenterol 96:1718-1724
37. Werner M, Flejou JF, Hainaut P, Höfler H, Lambert R, Keller G, Stein HJ. Adenocarcinoma of the oesophagus. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 20-26
38. Satgé D, Sasco AJ, Chompret A, Orbach D, Mechinaud F, Lacour B, Roullet B, Martelli H, Bergeron C, Bertrand Y, Lacombe D, Perel Y, Monteil P, Nelken B, Bertozzi AI, Munzer M, Kanold J, Bernard F, Vekemans MJ, Sommelet D (2003) A 22-year French experience with solid tumors in children with Down syndrome. Pediatr Hematol Oncol 20:517-529
39. Horacek J (1975) Saltykov's carcinoids on Down's syndrome. Description of two cases. Cesk Gastroenterol Vyz 29:275-277
40. Oster J, Mikkelsen M, Nielsen A (1975) Mortality and life-table in Down's syndrome. Acta Paediatr Scand 64:322-326
41. Jancar MP, Jancar J (1977) Cancer and mental retardation. Bristol Med-Chir J 92:3-7
42. Evenhuis HM, Oostindïer MJ, Steffelaar JW, Coebergh JW (1996) Incidentie van kanker bij mensen met een verstandelijke handicap; mogelijk verhoogd risico op slokdarmkanker. Ned Tijdschr Geneeskd 140:2083-2087
43. Spechler SJ, Dixon MF, Genta R, Hainaut P, Lambert R, Siewert R (2000) Adenocarcinoma of the oesophago-gastric junction. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 32-36
44. Böhmer CJM, Klinkenberg-Knol EC, Kuipers EJ, Niezen-deBoer MC, Schreuder H, Schuckink-Kool F, Meuwissen SG (1997) The prevalence of Helicobacter pylori infection among inhabitants and healthy employees of institutes for the intellectually disabled. Am J Gastroenterol 92:1000-1004
45. Duff M, Scheepers M, Cooper M, Hoghton M, Baddeley P (2001) Helicobacter pylori: Has the killer escaped from the institution? A possible cause of increased stomach cancer in a population with intellectual disability. J Intel Disab Res 45:219-225
46. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789
47. Sakata K, Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R (1997) Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach. Genes Chromos Cancer 18:318-321
48. Park WS, Oh RR, Park JY, Yoo NJ, Lee SH, Shin MS, Kim SY, Kim YS, Lee JH, Kim HS, An WG, Lee JY (2000) Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett 159:15-21
49. Lefebvre O, Chenard M-P, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274:259-262
50. Satgé D, Sasco AJ, Geneix A, Malet P (1998) Another reason to look for tumor suppressor genes on chromosome 21. Genes Chromos Cancer 21:1
51. Patankar T, Prasad S, Joshi A, Deshmukh H (1998) Jejunal angiomatoses causing small bowel obstruction in a patient with Down syndrome:a case report. J Postgrad Med 44:16-18
52. Pueschel SM, Romano C, Failla P, Barone C, Pettinato R, Castellano Chiodo A, Plumari DL (1999) A prevalence study of celiac disease in persons with Down syndrome residing in the United States of America. Acta Paediatr 88:953-966
53. Gascoyne RD, Müller-Hermelink HK, Chott A, Wotherspoon A (2000) Intestinal T-cell lymphoma. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 87-89
54. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Sategna Guidetti C, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M, Club del Tenue Study Group (2001) Mortality in patients with coeliac disease and their relatives: A cohort study. Lancet 358:356-361
55. Bettini AC, Beretta GD, Sironi P, Mosconi S, Labianca R (2003) Chemotherapy in small bowel adenocarcinoma associated with celiac disease: A report of three cases. Tumori 89:193-195
56. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, Rubio CA, Sobin LH, Fogt F, Winawer SJ, Goldgar DE, Jass JR (2000) Carcinoma of the colon and rectum. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 105-119
57. Holland WW, Doll R, Carter CO (1962) The mortality from leukaemia and other cancers among patients with Down's syndrome (mongols) and among their parents. Br J Cancer 16:177-186
58. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2004) Cancers and immune related diseases associated with Down's syndrome: A record linkage study. Arch Dis Child 89:1014-1017
59. Nakao K, Shibusawa M, Tsunoda A, Yoshizawa H, Murakami M, Kusano M, Uesugi N, Sasaki K (1998) Genetic changes in primary colorectal cancer by comparative genomic hybridization. Jpn J Surg 28:567-569
60. De Young MP, Tress M, Narayana R (2003) Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. Cancer Lett 200:25-31
61. Choi SW, Mason JB (2000) Folate and carcinogenesis: An integrated scheme. J Nutr 130:129-132
62. Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ (2001) Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69:88-95
63. Foos G, Garcia-Ramirez JJ, Galang CK, Hauser CA (1998) Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J Biol Chem 273:18871-18880
64. Carethers JM (2003) Biology and genetics of colorectal cancer. In Rustgi AK, Crawford JM (eds) Gastrointestinal cancers. Saunders, Toronto, pp 407-419
65. Bianca S, Ettore G (2000) Anorectal malformations and Down's syndrome. Paediatr Perinat Epidemiol 14:372
66. Albano G, Pugliese A, Stabile M, Sirimarco F, Arsieri R (1998) Hydrops foetalis caused by hepatic haemangioma. Acta Paedriatr 87:1307-1309
67. Aquino A, Domini M, Rossi C, Sardella L, Palka G, Chiesa PL (1998) Correlation between Down's syndrome and malformations of pediatric surgical interest. J Pediatr Surg 33:1380-1382
68. Gonzalez-Crussi F, Upton MP, Maurer HS (1982) Hepatoblastoma. Attempt at characterization of histologic subtypes. Am J Surg Pathol 6:599-612
69. Torfs CP, Christianson RE (1998) Anomalies in Down's syndrome individuals in a large population-based registry. Am J Med Genet 77:431-438
70. Fraumeni JF, Miller RW, Hill JA (1968) Primary carcinoma of the liver in childhood: An epidemiologic study. J Natl Cancer Inst 40:1087-1099
71. Miller RW (1970) Neoplasia and Down's syndrome. Ann NY Acad Sci 171:637-644
72. Hirohashi S, Ishak KG, Kojiro M, Wanless IR, Theise ND, Tsukuma H, Blum HE, Deugnier Y, Laurent Puig P, Fischer HP, Sakamoto M (2000) Hepatocellular carcinoma. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 159-172
73. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917
74. Martin BA (1997) Primary care of adults with mental retardation living in the community. Am Fam Phys 56:485-494
75. Piccione M, De Curtis M, La Vecchia ML, Novissimo A, Vajro P (1997) Hepatitis B and C infection in children with Down syndrome. Eur J Pediatr 156:420-421
76. Roizen NJ, Patterson D (2003) Down's syndrome. Lancet 361:1281-1289
77. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A (1997) Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromos Cancer 18:59-65
78. Patja K, Eero P, Livanainen M (2001) Cancer incidence among people with intellectual disability. J Intel Disab Res 45:300-307
79. Albores-Saavedra J, Scoazec JC, Wittekind C, Sripa B, Menck HR, Soehendra N, Sriram PVJ (2000) Carcinoma of the gallbladder and extrahepatic bile ducts. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 206-214
80. Tazuma S, Kajiyama G (2001) Carcinogenesis of malignant lesions of the gallbladder. The impact of chronic inflammation and gallstones. Langenbeck's Arch Surg 386:224-229
81. Nakanuma Y, Sripa B, Vatanasapt V, Leong AS-Y, Ponchon T, Ishak KG (2000) Intrahepatic cholangiocarcinoma. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 173-180
82. Llerena JC, Boy R, Neto JB, Vargas F, Fontana C, Cabral de Almeida JC (1993) Abdominal ultrasound scan in Down syndrome patients: High frenquency of nonsymptomatic biliary tract disease. Am J Med Genet 46:612
83. Aynaci FM, Erduran E, Mocan H, Okten A, Sarpkaya AO (1995) Cholelithiasis in infants with Down syndrome:report of two cases. Acta Paediat 84:711-712
84. Toscano E, Trivellini V, Andria G (2001) Cholelithiasis in Down's syndrome. Arch Dis Child 85:242-243
85. Tasdemir HA, Cetinkaya MC, Polat C, Belet U, Kalayci AG, Akbas S (2004) Gallbladder motility in children with Down syndrome J Pediatr Gastroenterol Nutr 39:187-191
86. Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B, Lehn N, Lowenfels AB, Lohr M (2002) Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 95:1946-1953
87. Gorunova L, Parada LA, Limon J, Jin Y, Hallen M, Hagerstrand I, Iliszko M, Wajda Z, Johansson B (1999) Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas. Genes Chromos Cancer 26:312-321
88. Dubois JJ, Cheng J, Pokorny WJ (1995) Inflammatory pseudocyst associated with trisomy 21 and Hirschsprung's disease. Milit Med 160:477-479
89. Morgan JR (1989) A case of Down's syndrome, insulinoma and anorexia. J Ment Defic Res 33:185-187
90. Turner JH (1963) The mongoloid phenotype: Its incidence, etiology and association with leukemia and other neoplastic disease. Thesis. University microfilms 63-7539, Ann Arbor, MI
91. Cole G, Neal JW, Fraser WI, Cowie VA (1994) Autopsy findings in patients with mental handicap. J Intel Disab Res 38:9-26
92. Rosewicz S, Wiedenmann B (1997) Pancreatic carcinoma. Lancet 349:485-489
93. Sasco AJ, Gendre I, Couris C (1998) Epidémiologie du cancer du pancréas, ou la recherche étiologique au service de la clinique. Cahiers Oncol 5:189-203
94. Klöppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ (2000) Ductal adenocarcinoma of the pancreas. In Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 221-230
95. Sirivatanauksorn V, Sirivatanauksorn Y, Gorman PA, Davidson JM, Sheer D, Moore PS, Scarpa A, Edwards PA, Lemoine NR (2001) Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping. Int J Cancer 91:350-358
96. O'Brien KF, Tate K, Zaharia ES (1991) Mortality in a large southeastern facility for persons with mental retardation. Am J Ment Ret 95:397-403
97. Cooke LB (1997) Cancer and learning disability. J Intel Disab Res 41:312-316
98. Sullivan SG, Hussain R, Threlfall T, Bittles AH (2004) The incidence of cancer in people with intellectual disabilities. Cancer Causes Control 15:1021-1025
99. Iughetti P, Suzuki O, Godoi PH, Alves VA, Sertie AL, Zorick T, Soares F, Camargo A, Moreira ES, di Loreto C, Moreira-Filho CA, Simpson A, Oliva G, Passos-Bueno MR (2001) A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res 61:7375-7378
100. Zorick TS, Mustacchi Z, Bando SY, Zatz M, Moreira-Filho CA, Olsen B, Passos-Bueno MR (2001) High serum endostatin levels in Down syndrome: Implications for improved treatment and prevention of solid tumours. Eur J Hum Genet 9:811-814
101. Benard J, Beron-Gaillard N, Satge D (2005) Down's syndrome protects against breast cancer: Is a constitutional cell microenvironment the key? Int J Cancer 113:168-170
102. Nespoli L, Burgio GR, Ugazio AG, Maccario R (1993) Immunological features of Down's syndrome a review. J Intel Disab Res 37:543-551
103. Luke A, Sutton M, Schoeller DA, Roizen NJ (1996) Nutrient intake and obesity in prepubescent children with Down syndrome. J Am Diet Assoc 96:1262-1267